Coronavirus Update: Bharat's Vaccine Looks Good In New Analysis
Plus: Serum Sets India Price, RDIF Inks Korea Deal
New Phase III data show efficacy ranging up to 100% for Bharat Biotech's inactivated vaccine, while also in India, Serum Institute sets new prices for its vaccine. Meanwhile, Russia's RDIF strikes new production deals in South Korea.
